Phe19-Arg238, with C-terminal His Tag
30-35 KD(Reducing)
PBS, pH 7.2, 5%海藻糖
Reconstitute at less than 1 mg/mL according to the size in ultrapure water after rapid centrifugation .
· 12 months from date of receipt, lyophilized powder stored at -20 to -80℃.
· 3 months, -20 to -80℃ under sterile conditions after reconstitution.
· 1 week, 2 to 8℃ under sterile conditions after reconstitution.
· Please avoid repeated freeze-thaw cycles.
细胞程式死亡-配体1(Programmed cell death 1 ligand 1,PD-L1)是大小为 40kDa人类体内表达的第一型跨膜蛋白,据信其在某些特殊情形(例如怀孕、组织移植、自体免疫疾病,以及诸如肝炎等某些疾病)下,免疫系统的抑制有关。正常情形下免疫系统会对聚集在淋巴结或脾脏的外来抗原产生反应,促进抗原特异性的细胞毒杀性T细胞(CD8+ T cell)增生。而细胞程序化死亡受体-1(PD-1)与细胞程式死亡-配体1(PD-L1)结合,可以传导抑制性的信号,减低淋巴结CD8+ T细胞的增生,而且PD-1还可以借此调节Bcl-2基因,控制淋巴结中抗原特异性T细胞的聚积。本产品系由HEK293细胞株表达人源PD-L1,C-6His重组蛋白,经多步纯化后过滤、添加5%海藻糖、冻干制成。
Immobilized PD-L1 His Tag Protein, Human (Cat. No. UA010001) at 1.0μg/mL (100μL/well) can bind S-RMab® PD-L1 Recombinant Rabbit mAb (SDT-119-286) (Cat. No. S0B2287) with EC50 of 0.89-1.21ng/mL.